ScholarLens Back to search
2013•Cochrane Database of Systematic ReviewsRequires access

Drugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis

Nicolas Goossens, Graziella Isgrò, Francesco Negro

Open publisher page 1 citations

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the beneficial and harmful effects of drugs improving insulin resistance for non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis.

About this research paper

What this paper is about

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the beneficial and harmful effects of drugs improving insulin resistance for non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the beneficial and harmful effects of drugs improving insulin resistance for non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis.

Key concepts: Steatohepatitis, Insulin resistance, Fatty liver, Medicine, Alcoholic liver disease, Disease, Insulin, Internal medicine

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Drugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis — Research Paper | ScholarLens